Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease

TS Plantinga; P Arts; GH Knarren; AH Mulder; IM Wakelkamp; AR Hermus; LA Joosten; MG Netea; PH Bisschop; W.W. de Herder; HJ Beijers; IJ de Bruin; C Gilissen; JA Veltman; A Hoischen; JW Smit; RT Netea-Maier

doi:10.1002/cpt.733

Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease

TS Plantinga, P Arts, GH Knarren, AH Mulder, IM Wakelkamp, AR Hermus, LA Joosten, MG Netea, PH Bisschop, W.W. de Herder, HJ Beijers, IJ de Bruin, C Gilissen, JA Veltman, A Hoischen, JW Smit, RT Netea-Maier

Research output: Contribution to journal › Article › Academic › peer-review

12 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1017-1024
Number of pages	8
Journal	Clinical Pharmacology & Therapeutics
Volume	102
Issue number	6
DOIs	https://doi.org/10.1002/cpt.733
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1002/cpt.733

http://hdl.handle.net/1765/108291

Cite this

Plantinga, TS., Arts, P., Knarren, GH., Mulder, AH., Wakelkamp, IM., Hermus, AR., Joosten, LA., Netea, MG., Bisschop, PH., de Herder, W. W., Beijers, HJ., de Bruin, IJ., Gilissen, C., Veltman, JA., Hoischen, A., Smit, JW., & Netea-Maier, RT. (2017). Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease. Clinical Pharmacology & Therapeutics, 102(6), 1017-1024. https://doi.org/10.1002/cpt.733

@article{9d6d81d4b057476990e70f563314a17e,

title = "Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease",

author = "TS Plantinga and P Arts and GH Knarren and AH Mulder and IM Wakelkamp and AR Hermus and LA Joosten and MG Netea and PH Bisschop and {de Herder}, W.W. and HJ Beijers and {de Bruin}, IJ and C Gilissen and JA Veltman and A Hoischen and JW Smit and RT Netea-Maier",

year = "2017",

doi = "10.1002/cpt.733",

language = "Undefined/Unknown",

volume = "102",

pages = "1017--1024",

journal = "Clinical Pharmacology & Therapeutics",

issn = "0009-9236",

publisher = "Wiley-Blackwell",

number = "6",

}

Plantinga, TS, Arts, P, Knarren, GH, Mulder, AH, Wakelkamp, IM, Hermus, AR, Joosten, LA, Netea, MG, Bisschop, PH, de Herder, WW, Beijers, HJ, de Bruin, IJ, Gilissen, C, Veltman, JA, Hoischen, A, Smit, JW & Netea-Maier, RT 2017, 'Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease', Clinical Pharmacology & Therapeutics, vol. 102, no. 6, pp. 1017-1024. https://doi.org/10.1002/cpt.733

TY - JOUR

T1 - Rare NOX3 Variants Confer Susceptibility to Agranulocytosis During Thyrostatic Treatment of Graves' Disease

AU - Plantinga, TS

AU - Arts, P

AU - Knarren, GH

AU - Mulder, AH

AU - Wakelkamp, IM

AU - Hermus, AR

AU - Joosten, LA

AU - Netea, MG

AU - Bisschop, PH

AU - de Herder, W.W.

AU - Beijers, HJ

AU - de Bruin, IJ

AU - Gilissen, C

AU - Veltman, JA

AU - Hoischen, A

AU - Smit, JW

AU - Netea-Maier, RT

PY - 2017

Y1 - 2017

U2 - 10.1002/cpt.733

DO - 10.1002/cpt.733

M3 - Article

C2 - 28486791

SN - 0009-9236

VL - 102

SP - 1017

EP - 1024

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

IS - 6

ER -